FDA approves overdose drug Narcan as 1st over-the-counter opioid treatment

The Food and Drug Administration on Wednesday approved over-the-counter sales of Narcam, the leading version of the opioid overdose reversal drug naloxone. Narcan is the first opioid treatment to get approval for sale without a prescription, and advocates and the Biden administration hope wider distribution will cut the number of Americans dying from fentanyl, heroin, oxycodone, and other opioid overdoses. Almost two-thirds of the 107,000 U.S. overdose deaths recorded in 2021 were from the synthetic opioid fentanyl.
Addiction and overdose experts said the efficacy of selling Narcan over the counter will depend on how many stores decide to stock it, where and how they display it on shelves, whether insurance plans will cover it, and how much its manufacturer, Emergent BioSolutions, decides to charge for a two-dose nasal spray package. Currently, the two-dose package of Narcan reportedly sells for about $47.
The FDA is likely to approve a second OTC naloxone spray, RiVine, which the nonprofit Harm Reduction Therapeutics sells for about $18 a unit, The Washington Post reports, and generic versions would be even cheaper if approved.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The FDA said, after Emergent studied the issue, that Narcan requires no specialty training to administer. One dose typically revives people overdosing on opioids, though fentanyl overdoses can require several doses. Before administering Narcan, people should call 911 and request an ambulance. Emergent said Narcan should be available on store shelves by late summer.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Discrimination: Expanding the definition
Feature The Supreme Court ruled in favor of a straight woman who sued her gay boss for discrimination
-
Crime: Why murder rates are plummeting
Feature Despite public fears, murder rates have dropped nationwide for the third year in a row
-
Education: America First vs. foreign students
Feature Trump's war on Harvard escalates as he blocks foreign students from enrolling at the university
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
-
Shingles vaccine cuts dementia risk, study finds
Speed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia
-
Measles outbreak spreads, as does RFK Jr.'s influence
Speed Read The outbreak centered in Texas has grown to at least three states and Health Secretary Robert F. Kennedy Jr. is promoting unproven treatments